Back

Long-term clinical outcomes of beta-blocker therapy in elderly patients with preserved left ventricular function after percutaneous coronary intervention for acute myocardial infarction

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition Beta-Blockers ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Assistant Professor Jeong Cheon Choe

Pusan National University Hospital, Pusan (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Effect of beta-blockers on cardiovascular hospitalisation after myocardial infarction: A substudy of the BETAMI-DANBLOCK trial.
Doctor H. Caglar (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Troponin-stratified outcomes of extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome: insights from the OPT-BIRISK randomized trial
Professor M. Qiu (Shenyang, CN)
Abstract Slides Video
Presentation thumbnail
Coordinated post-myocardial infarction care versus the PCSK9 modulator drug program: a comparative outcomes study
Professor M. Banach (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Long-term effect of beta-blockers after myocardial infarction with preserved left ventricular ejection fraction in a per protocol analysis of the REDUCE-AMI trial
Professor T. Jernberg (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Influence of diabetes on platelet inhibition in patients with acute coronary syndrome treated with prasugrel or ticagrelor
Doctor F. Simonetti (Munich, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Beta-blocker therapy and all-cause mortality after percutaneous coronary intervention: a state-wide propensity score matched analysis stratified by left ventricular ejection fraction
31 August 2026
thumbnail
Congress Presentation
Prognostic significance of cardiac 123I-metaiodobenzylguanidine imaging in heart failure with preserved ejection fraction
28 August 2026
thumbnail
Congress Presentation
Late residual risk between 12 and 36 months after event-free survival following acute myocardial infarction
30 August 2026
thumbnail
Congress Presentation
Comparative clinical outcomes of carvedilol versus bisoprolol in STEMI survivors after primary PCI: a propensity-score matched analysis
31 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources